Skip to main content

Table 3 Application of VLPs as drug delivery

From: Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers

References

Application

Cargo

(Drug, Nucleic acids, Proteins)

VLP

[210,211,212]

Tumor therapy

Bleomycin (BLM)

Paclitaxel (PTX)

mRNA cap analog

Adenovirus (AdV)

[213]

Tumor therapy

Doxorubicin, Cisplatin, 5-fluorouracil

siRNA

Ricin toxin A-chain (RTA)

Bacteriophage MS2

[214]

Tumor therapy

Doxorubicin (DOX)

Rotavirus [66]

[215]

Tumor therapy

Doxorubicin (DOX)

Cowpea mosaic virus (CPMV)

[216]

Tumor therapy

Doxorubicin (Dox)

Cucumber mosaic virus (CMV)

[217]

Tumor therapy

siRNA

Hepatitis B virus (HBV)

[218]

Tumor therapy

Methotrexate (MTX)

Polyomavirus

[219]

Antimicrobial drug

Chloramphenicol

Filamentous bacteriophages

(fd or M13)

[220]

Antimicrobial drug

Azithromycin/clarithromycin

Bacteriophage Qβ